Showing results (351-360 of 5,984) with videos related to
Sort By:
Pageof 599
Molecular Cancer Therapeutics|October 6, 2017
The Irreversible Covalent Fibroblast Growth Factor Receptor Inhibitor PRN1371 Exhibits Sustained Inhibition of FGFR after Drug ClearanceEleni Venetsanakos, Ken A Brameld, Vernon T Phan, et al.Molecular Cancer Therapeutics|March 30, 2018
Analysis of HSP27 and the Autophagy Marker LC3B+ Puncta Following Preoperative Chemotherapy Identifies High-Risk Osteosarcoma PatientsJ Andrew Livingston, Wei-Lien Wang, Jen-Wei Tsai, et al.Molecular Cancer Therapeutics|March 30, 2018
Itraconazole-Induced Inhibition on Human Esophageal Cancer Cell Growth Requires AMPK ActivationMin-Bin Chen, Yuan-Yuan Liu, Zhao-Yu Xing, et al.Molecular Cancer Therapeutics|March 30, 2018
Trastuzumab-Resistant HER2+ Breast Cancer Cells Retain Sensitivity to Poly (ADP-Ribose) Polymerase (PARP) InhibitionMonica E Wielgos, Zhuo Zhang, Rajani Rajbhandari, et al.Molecular Cancer Therapeutics|March 30, 2018
Nano-Engineered Mesenchymal Stem Cells Increase Therapeutic Efficacy of Anticancer Drug Through True Active Tumor TargetingBuddhadev Layek, Tanmoy Sadhukha, Jayanth Panyam, et al.Molecular Cancer Therapeutics|March 17, 2018
Acquired Resistance to a MET Antibody In Vivo Can Be Overcome by the MET Antibody Mixture Sym015Sofie Ellebaek Pollmann, Valerie S Calvert, Shruti Rao, et al.Molecular Cancer Therapeutics|March 17, 2018
A miR-29b Byproduct Sequence Exhibits Potent Tumor-Suppressive Activities via Inhibition of NF-κB Signaling in KRAS-Mutant Colon Cancer CellsAkira Inoue, Tsunekazu Mizushima, Xin Wu, et al.Molecular Cancer Therapeutics|March 17, 2018
ICEC0942, an Orally Bioavailable Selective Inhibitor of CDK7 for Cancer TreatmentHetal Patel, Manikandan Periyasamy, Georgina P Sava, et al.Molecular Cancer Therapeutics|February 28, 2018
Analysis of Tissue and Circulating Tumor DNA by Next-Generation Sequencing of Hepatocellular Carcinoma: Implications for Targeted TherapeuticsSadakatsu Ikeda, Jordan S Lim, Razelle KurzrockMolecular Cancer Therapeutics|February 28, 2018
MCT4 Expression Is a Potential Therapeutic Target in Colorectal Cancer with Peritoneal CarcinomatosisHee Kyung Kim, InKyoung Lee, Heejin Bang, et al.Pageof 599